Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Sep 1;14(17):4284. doi: 10.3390/cancers14174284

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Overall survival time in patients who developed each AE in atezo/beva treatments. (A) Kaplan–Meier curves for overall survival according to whether a liver disorder is present. The blue line indicates the liver injury group. The red line indicates the no liver injury group. (B) Kaplan–Meier curves for overall survival according to whether there is hypertension. The red line indicates the hypertension group. The blue line indicates the no hypertension group. (C) Kaplan–Meier curves for overall survival according to whether there are skin disorders. The red line indicates the skin disorder group. The blue dotted line indicates the no skin disorder group. AE, adverse events; atezo/beva, atezolizumab plus bevacizumab.